The Headache and Migraine Disease Working Group is a network of policy-minded health care providers who advocate for patient-centered care.

By participating in advocacy initiatives and the development of educational resources, working group members ensure that the clinician’s perspective informs policy discussions that impact health care for people living with headache disorders or migraine disease.

To learn more, or to join AfPA’s Headache and Migraine Disease Working Group, please email info@allianceforpatientaccess.org.

Resources

White Papers & Policy Briefs

• Prior Authorization & Treatment Delays
  The Headache & Migraine Policy Forum, Movement Disorders Policy Coalition, Alliance for Patient Access, February 2021
• Telemedicine: A Position Statement
  Alliance for Patient Access, July 2020
• In Conversation: A Physician Discusses COVID-19 and Migraine Treatment
  Alliance for Patient Access, May 2020
• High Out-of-Pocket Costs: A Position Statement
  Alliance for Patient Access, July 2019
• Non-Medical Switching: A Position Statement
  Alliance for Patient Access, July 2019
• Treatment Challenges for People with Headache and Migraine Disease
  Institute for Patient Access, June 2019
• Co-Pay Accumulator Programs: A Position Statement
  Alliance for Patient Access, May 2019
• Prior Authorization: A Position Statement
  Alliance for Patient Access, April 2019
• A Study of the Qualitative Impact of Non-Medical Switching | Abstract
  Alliance for Patient Access, February 2019
• Step Therapy: A Position Statement
  Alliance for Patient Access, January 2019
• Botulinum Neurotoxins and Non-Medical Switching
  Institute for Patient Access, December 2018
• ICER Case Study: Migraine
  Institute for Patient Access, April 2018

Videos

• The Pain of Waiting for Migraine Medication
  Alliance for Patient Access, February 2021
• Why Health Care Providers Should Care About ICER
  Institute for Patient Access, November 2019
• Maureen Moriarty, DNP, on Barriers to Migraine Treatment
  Alliance for Patient Access, November 2019
• Heather McCoy, DrNP, on Barriers to Migraine Treatment
  Alliance for Patient Access, November 2019
• Christopher Gottschalk, MD, on Barriers to Migraine Treatment
  Alliance for Patient Access, November 2019
• My Migraine Patients’ Combination Therapy Battle
  Alliance for Patient Access, September 2019
• Non-Medical Switching Hurts Patients
  Alliance for Patient Access, March 2019
• Non-Medical Switching of Neurotoxins
  Alliance for Patient Access, February 2019

Infographics

• Are Insurers Out of Step on Migraine Disease?
  Alliance for Patient Access, June 2021
• When Insurers Limit Migraine Patients
  Alliance for Patient Access, February 2021
• How Excessive Prior Authorization Hurts Patients
  Alliance for Patient Access, December 2020
• Migraine Disease is a Spectrum
  The Headache and Migraine Policy Forum, October 2019
• Women, Migraine Disease & the Workplace
  The Headache and Migraine Policy Forum, June 2019
• Why Can’t Migraine Patients Access Combination Therapy?
  The Headache and Migraine Policy Forum, May 2019
• How Non-Medical Switching Hurts Patients
  Alliance for Patient Access, February 2019
• Migraine & Disability
  The Headache and Migraine Policy Forum, February 2019
• The Problem with Prescribing Restrictions for Migraine Medications
  The Headache Migraine Policy Forum, January 2019
• Non-Medical Switching of Neurotoxins
  Alliance for Patient Access, October 2018